{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:36:19Z","timestamp":1776749779813,"version":"3.51.2"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00284-026-04788-3","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:27:39Z","timestamp":1772177259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic Immunoenhancement of Recombinant PBP2a Vaccine Candidate by Biogenic Selenium Nanoparticles and MF59 Against Methicillin-Resistant Staphylococcus Aureus"],"prefix":"10.1007","volume":"83","author":[{"given":"Mahya","family":"Daneshpajooh Rahmani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8567-8555","authenticated-orcid":false,"given":"Mohammad Hossein","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6605-5245","authenticated-orcid":false,"given":"Setareh","family":"Haghighat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Zarrinpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"6","key":"4788_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41579-023-00852-y","volume":"21","author":"BP Howden","year":"2023","unstructured":"Howden BP, Giulieri SG, Wong Fok Lung T, Baines SL, Sharkey LK, Lee JY, Hachani A, Monk IR, Stinear TP (2023) Staphylococcus aureus host interactions and adaptation. Nat Rev Microbiol 21(6):380\u2013395. https:\/\/doi.org\/10.1038\/s41579-023-00852-y","journal-title":"Nat Rev Microbiol"},{"key":"4788_CR2","doi-asserted-by":"publisher","unstructured":"Abebe AA, Birhanu AG (2023) Methicillin resistant Staphylococcus aureus: molecular mechanisms underlying drug resistance development and novel strategies to combat. Infection and drug resistance:7641\u20137662. https:\/\/doi.org\/10.1038\/s41579-023-00852-y","DOI":"10.1038\/s41579-023-00852-y"},{"issue":"5","key":"4788_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jobm.202300579","volume":"64","author":"M Gopikrishnan","year":"2024","unstructured":"Gopikrishnan M, Haryini S (2024) Emerging strategies and therapeutic innovations for combating drug resistance in Staphylococcus aureus strains: a comprehensive review. J Basic Microbiol 64(5):2300579. https:\/\/doi.org\/10.1002\/jobm.202300579","journal-title":"J Basic Microbiol"},{"issue":"19","key":"4788_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196281","volume":"27","author":"S Sadiqi","year":"2022","unstructured":"Sadiqi S, Hamza M, Ali F, Alam S, Shakeela Q, Ahmed S, Ayaz A, Ali S, Saqib S, Ullah F (2022) Molecular characterization of bacterial isolates from soil samples and evaluation of their antibacterial potential against MDRS. Molecules 27(19):6281. https:\/\/doi.org\/10.3390\/molecules27196281","journal-title":"Molecules"},{"issue":"4","key":"4788_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2023.103604","volume":"30","author":"BA Alghamdi","year":"2023","unstructured":"Alghamdi BA, Al-Johani I, Al-Shamrani JM, Alshamrani HM, Al-Otaibi BG, Almazmomi K, Yusof NY (2023) Antimicrobial resistance in methicillin-resistant Staphylococcus aureus. Saudi J Biol Sci 30(4):103604. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103604","journal-title":"Saudi J Biol Sci"},{"issue":"7","key":"4788_CR6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1592\/phco.27.7.1001","volume":"27","author":"TP Lodise Jr","year":"2007","unstructured":"Lodise TP Jr, McKinnon PS (2007) Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes. Pharmacotherapy 27(7):1001\u20131012. https:\/\/doi.org\/10.1592\/phco.27.7.1001","journal-title":"Pharmacotherapy"},{"issue":"9","key":"4788_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12091362","volume":"12","author":"H Lade","year":"2023","unstructured":"Lade H, Kim J-S (2023) Molecular determinants of \u03b2-lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA): an updated review. Antibiotics 12(9):1362. https:\/\/doi.org\/10.3390\/antibiotics12091362","journal-title":"Antibiotics"},{"key":"4788_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.intimp.2018.01.035","volume":"56","author":"RZ Naghshbandi","year":"2018","unstructured":"Naghshbandi RZ, Haghighat S, Mahdavi M (2018) Passive immunization against methicillin resistant Staphylococcus aureus recombinant PBP2a in sepsis model of mice: comparable results with antibiotic therapy. Int Immunopharmacol 56:186\u2013192. https:\/\/doi.org\/10.1016\/j.intimp.2018.01.035","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"4788_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14050470","volume":"14","author":"R Touaitia","year":"2025","unstructured":"Touaitia R, Mairi A, Ibrahim NA, Basher NS, Idres T, Touati A (2025) Staphylococcus aureus: a review of the pathogenesis and virulence mechanisms. Antibiotics 14(5):470. https:\/\/doi.org\/10.3390\/antibiotics14050470","journal-title":"Antibiotics"},{"key":"4788_CR10","doi-asserted-by":"publisher","unstructured":"Arshad B, Iqbal T, Bhatti KP, Ahmed S (2021) Insights into Off-Label therapeutic strategies against mild and severe COVID-19 infection. Pak J Pharm Sci 34(4). https:\/\/doi.org\/10.36721\/PJPS.2021.34.4.REG.1469-1484.1. https:\/\/doi.org\/","DOI":"10.36721\/PJPS.2021.34.4.REG.1469-1484.1"},{"issue":"8","key":"4788_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1039\/C9MD00044E","volume":"10","author":"KM Craft","year":"2019","unstructured":"Craft KM, Nguyen JM, Berg LJ, Townsend SD (2019) Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype. MedChemComm 10(8):1231\u20131241. https:\/\/doi.org\/10.1039\/C9MD00044E","journal-title":"MedChemComm"},{"issue":"1","key":"4788_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/cmdc.202000677","volume":"16","author":"S Cascioferro","year":"2021","unstructured":"Cascioferro S, Carbone D, Parrino B, Pecoraro C, Giovannetti E, Cirrincione G, Diana P (2021) Therapeutic strategies to counteract antibiotic resistance in MRSA biofilm-associated infections. ChemMedChem 16(1):65\u201380. https:\/\/doi.org\/10.1002\/cmdc.202000677","journal-title":"ChemMedChem"},{"issue":"8","key":"4788_CR13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1089\/sur.2018.263","volume":"19","author":"PS Barie","year":"2018","unstructured":"Barie PS, Narayan M, Sawyer RG (2018) Immunization against Staphylococcus aureus infections. Surg Infect 19(8):750\u2013756. https:\/\/doi.org\/10.1089\/sur.2018.263","journal-title":"Surg Infect"},{"key":"4788_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705360","volume":"12","author":"J Clegg","year":"2021","unstructured":"Clegg J, Soldaini E, McLoughlin RM, Rittenhouse S, Bagnoli F, Phogat S (2021) Staphylococcus aureus vaccine research and development: the past, present and future, including novel therapeutic strategies. Front Immunol 12:705360. https:\/\/doi.org\/10.3389\/fimmu.2021.705360","journal-title":"Front Immunol"},{"key":"4788_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1493915","volume":"15","author":"A Yarahmadi","year":"2025","unstructured":"Yarahmadi A, Najafiyan H, Yousefi MH, Khosravi E, Shabani E, Afkhami H, Aghaei SS (2025) Beyond antibiotics: exploring multifaceted approaches to combat bacterial resistance in the modern era: a comprehensive review. Front Cell Infect Microbiol 15:1493915. https:\/\/doi.org\/10.3389\/fcimb.2025.1493915","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"4788_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050819","volume":"10","author":"A Facciol\u00e0","year":"2022","unstructured":"Facciol\u00e0 A, Visalli G, Lagan\u00e0 A, Di Pietro A (2022) An overview of vaccine adjuvants: current evidence and future perspectives. Vaccines 10(5):819. https:\/\/doi.org\/10.3390\/vaccines10050819","journal-title":"Vaccines"},{"issue":"1","key":"4788_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y, Tian X (2023) Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther 8(1):283. https:\/\/doi.org\/10.1038\/s41392-023-01557-7","journal-title":"Signal Transduct Target Ther"},{"issue":"17","key":"4788_CR18","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1039\/D3TB02861E","volume":"12","author":"Y Cui","year":"2024","unstructured":"Cui Y, Ho M, Hu Y, Shi Y (2024) Vaccine adjuvants: current status, research and development, licensing, and future opportunities. J Mater Chem B 12(17):4118\u20134137. https:\/\/doi.org\/10.1039\/D3TB02861E","journal-title":"J Mater Chem B"},{"key":"4788_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcab.2020.101729","volume":"28","author":"S Saqib","year":"2020","unstructured":"Saqib S, Zaman W, Ayaz A, Habib S, Bahadur S, Hussain S, Muhammad S, Ullah F (2020) Postharvest disease inhibition in fruit by synthesis and characterization of chitosan iron oxide nanoparticles. Biocatal Agric Biotechnol 28:101729. https:\/\/doi.org\/10.1016\/j.bcab.2020.101729","journal-title":"Biocatal Agric Biotechnol"},{"issue":"7","key":"4788_CR20","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3390\/antibiotics12010087","volume":"11","author":"B Filipi\u0107","year":"2023","unstructured":"Filipi\u0107 B, Panteli\u0107 I, Nikoli\u0107 I, Majhen D, Stoji\u0107-Vukani\u0107 Z, Savi\u0107 S, Kraji\u0161nik D (2023) Nanoparticle-based adjuvants and delivery systems for modern vaccines. Vaccines 11(7):1172. https:\/\/doi.org\/10.3390\/antibiotics12010087","journal-title":"Vaccines"},{"issue":"25","key":"4788_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz446","volume":"6","author":"X Hong","year":"2020","unstructured":"Hong X, Zhong X, Du G, Hou Y, Zhang Y, Zhang Z, Gong T, Zhang L, Sun X (2020) The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency. Sci Adv 6(25):eaaz4462. https:\/\/doi.org\/10.1126\/sciadv.aaz446","journal-title":"Sci Adv"},{"issue":"2","key":"4788_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/1061186X.2024.2412142","volume":"33","author":"MA Waqar","year":"2025","unstructured":"Waqar MA (2025) A comprehensive review on recent advancements in drug delivery via selenium nanoparticles. J Drug Target 33(2):157\u2013170. https:\/\/doi.org\/10.1080\/1061186X.2024.2412142","journal-title":"J Drug Target"},{"issue":"1","key":"4788_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09598-z","volume":"51","author":"JA Ansari","year":"2024","unstructured":"Ansari JA, Malik JA, Ahmed S, Manzoor M, Ahemad N, Anwar S (2024) Recent advances in the therapeutic applications of selenium nanoparticles. Mol Biol Rep 51(1):688. https:\/\/doi.org\/10.1007\/s11033-024-09598-z","journal-title":"Mol Biol Rep"},{"key":"4788_CR24","doi-asserted-by":"publisher","DOI":"10.26599\/NBE.2024.9290100","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu Y, Yang Q, Liu T (2024) The application of selenium nanoparticles in immunotherapy. Nano Biomed Eng. https:\/\/doi.org\/10.26599\/NBE.2024.9290100","journal-title":"Nano Biomed Eng"},{"issue":"16","key":"4788_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202100598","volume":"10","author":"C Ferro","year":"2021","unstructured":"Ferro C, Florindo HF, Santos HA (2021) Selenium nanoparticles for biomedical applications: from development and characterization to therapeutics. Adv Healthc Mater 10(16):2100598. https:\/\/doi.org\/10.1002\/adhm.202100598","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"4788_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s11274-022-03455-6","volume":"39","author":"A Ranjbariyan","year":"2023","unstructured":"Ranjbariyan A, Haghighat S, Yazdi MH, Arbabi Bidgoli S (2023) Synthetic selenium nanoparticles as co-adjuvant improved immune responses against methicillin-resistant Staphylococcus aureus. World J Microbiol Biotechnol 39(1):16. https:\/\/doi.org\/10.1007\/s11274-022-03455-6","journal-title":"World J Microbiol Biotechnol"},{"key":"4788_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1557415","volume":"16","author":"J Xing","year":"2025","unstructured":"Xing J, Zhao X, Li X, Fang R, Sun M, Zhang Y, Song N (2025) The recent advances in vaccine adjuvants. Front Immunol 16:1557415. https:\/\/doi.org\/10.3389\/fimmu.2025.1557415","journal-title":"Front Immunol"},{"issue":"12","key":"4788_CR28","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1080\/21645515.2018.1495301","volume":"14","author":"E-J Ko","year":"2018","unstructured":"Ko E-J, Kang S-M (2018) Immunology and efficacy of MF59-adjuvanted vaccines. Hum Vaccin Immunother 14(12):3041\u20133045. https:\/\/doi.org\/10.1080\/21645515.2018.1495301","journal-title":"Hum Vaccin Immunother"},{"key":"4788_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.micpath.2017.04.037","volume":"108","author":"S Haghighat","year":"2017","unstructured":"Haghighat S, Siadat SD, Sorkhabadi SMR, Sepahi AA, Sadat SM, Yazdi MH, Mahdavi M (2017) Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: immunogenicity and protectivity. Microb Pathog 108:32\u201339. https:\/\/doi.org\/10.1016\/j.micpath.2017.04.037","journal-title":"Microb Pathog"},{"issue":"8","key":"4788_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/iub.1289","volume":"66","author":"J Fishovitz","year":"2014","unstructured":"Fishovitz J, Hermoso JA, Chang M, Mobashery S (2014) Penicillin-binding protein 2a of methicillin\u2010resistant Staphylococcus aureus. IUBMB Life 66(8):572\u2013577. https:\/\/doi.org\/10.1002\/iub.1289","journal-title":"IUBMB Life"},{"issue":"10","key":"4788_CR31","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/biology11101523","volume":"11","author":"F Yanez-Lemus","year":"2022","unstructured":"Yanez-Lemus F, Moraga R, Smith CT, Aguayo P, S\u00e1nchez-Alonzo K, Garc\u00eda-Cancino A, Valenzuela A, Campos VL (2022) Selenium nanoparticle-enriched and potential probiotic, Lactiplantibacillus plantarum S14 strain, a diet supplement beneficial for rainbow trout. Biology 11(10):1523. https:\/\/doi.org\/10.3390\/biology11101523","journal-title":"Biology"},{"key":"4788_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2025.100650","volume":"24","author":"A Ranjbariyan","year":"2025","unstructured":"Ranjbariyan A, Haghighat S, Yazdi MH, Bidgoli SA, Tabriz HM, Mahdavi M (2025) Immunogenic potential of biogenic vs. synthetic selenium nanoparticles in vaccine candidate against methicillin-resistant Staphylococcus aureus. Vaccine: X 100650. https:\/\/doi.org\/10.1016\/j.jvacx.2025.100650","journal-title":"Vaccine: X"},{"key":"4788_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103945","volume":"140","author":"SS Mortazavi","year":"2020","unstructured":"Mortazavi SS, Haghighat S, Mahdavi M (2020) Recombinant PBP2a of methicillin-resistant S. aureus formulation in Alum and Montanide ISA266 adjuvants induced cellular and humoral immune responses with protection in Balb\/C mice. Microb Pathog 140:103945. https:\/\/doi.org\/10.1016\/j.micpath.2019.103945","journal-title":"Microb Pathog"},{"issue":"4","key":"4788_CR34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.22038\/IJBMS.2022.59992.13303","volume":"25","author":"S Haghighat","year":"2022","unstructured":"Haghighat S, Siadat SD, Sepahi AA, Mahdavi M (2022) Recombinant PBP2a\/autolysin conjugate as PLGA-based nanovaccine induced humoral responses with opsonophagocytosis activity, and protection versus methicillin-resistant Staphylococcus aureus infection. Iran J Basic Med Sci 25(4):442. https:\/\/doi.org\/10.22038\/IJBMS.2022.59992.13303","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"4788_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1099\/00222615-37-1-3","volume":"37","author":"L Siegfried","year":"1992","unstructured":"Siegfried L, Puzova H, Kmetcov\u00e1 M, Kereste\u0161ov\u00e1 A (1992) Killing of \u03b1-haemolytic and non-haemolytic Escherichia coli strains in human serum and polymorphonuclear leucocytes. J Med Microbiol 37(1):3\u20137. https:\/\/doi.org\/10.1099\/00222615-37-1-3","journal-title":"J Med Microbiol"},{"key":"4788_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micpath.2017.04.037","volume":"91","author":"S Haghighat","year":"2017","unstructured":"Haghighat S, Siadat SD, Sorkhabadi SMR, Sepahi AA, Mahdavi M (2017) A novel recombinant vaccine candidate comprising PBP2a and autolysin against Methicillin Resistant Staphylococcus aureus confers protection in the experimental mice. Mol Immunol 91:1\u20137. https:\/\/doi.org\/10.1016\/j.micpath.2017.04.037","journal-title":"Mol Immunol"},{"issue":"29","key":"4788_CR37","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","volume":"30","author":"D O\u2019hagan","year":"2012","unstructured":"O\u2019hagan D, Ott GS, De Gregorio E, Seubert A (2012) The mechanism of action of MF59\u2013an innately attractive adjuvant formulation. Vaccine 30(29):4341\u20134348. https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.061","journal-title":"Vaccine"},{"issue":"5","key":"4788_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1586\/14760584.6.5.699","volume":"6","author":"DT O\u2019Hagan","year":"2007","unstructured":"O\u2019Hagan DT (2007) MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection. Expert Rev Vaccines 6(5):699\u2013710. https:\/\/doi.org\/10.1586\/14760584.6.5.699","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"4788_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-023-03913-6","volume":"18","author":"PR Kumbhar","year":"2023","unstructured":"Kumbhar PR, Kumar P, Lasure A, Velayutham R, Mandal D (2023) An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success. Discover Nano 18(1):156. https:\/\/doi.org\/10.1186\/s11671-023-03913-6","journal-title":"Discover Nano"},{"issue":"25","key":"4788_CR40","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1039\/D1TB00533B","volume":"9","author":"W Zhang","year":"2021","unstructured":"Zhang W, Wu Y, Liu L, Xiao X, Cong Z, Shao N, Qiao Z, Chen K, Liu S, Zhang H (2021) The membrane-targeting mechanism of host defense peptides inspiring the design of polypeptide-conjugated gold nanoparticles exhibiting effective antibacterial activity against methicillin-resistant Staphylococcus aureus. J Mater Chem B 9(25):5092\u20135101. https:\/\/doi.org\/10.1039\/D1TB00533B","journal-title":"J Mater Chem B"},{"issue":"1","key":"4788_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jiph.2016.02.006","volume":"10","author":"M Mahdavi","year":"2017","unstructured":"Mahdavi M, Mavandadnejad F, Yazdi MH, Faghfuri E, Hashemi H, Homayouni-Oreh S, Farhoudi R, Shahverdi AR (2017) Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model. J Infect Public Health 10(1):102\u2013109. https:\/\/doi.org\/10.1016\/j.jiph.2016.02.006","journal-title":"J Infect Public Health"},{"issue":"1","key":"4788_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1049\/iet-nbt.2017.0006","volume":"12","author":"F Mavandadnejad","year":"2018","unstructured":"Mavandadnejad F, Yazdi MH, Hassanzadeh SM, Mahdavi M, Faramarzi MA, Pazoki-Toroudi H, Shahverdi AR (2018) Biosynthesis of SeNPs by Mycobacterium bovis and their enhancing effect on the immune response against HBs antigens: an in vivo study. IET Nanobiotechnol 12(1):57\u201363. https:\/\/doi.org\/10.1049\/iet-nbt.2017.0006","journal-title":"IET Nanobiotechnol"},{"issue":"1","key":"4788_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01371-1","volume":"8","author":"H Lai","year":"2023","unstructured":"Lai H, Xu L, Liu C, Shi S, Jiang Y, Yu Y, Deng B, Chen T (2023) Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine. Signal Transduct Target Ther 8(1):88. https:\/\/doi.org\/10.1038\/s41392-023-01371-1","journal-title":"Signal Transduct Target Ther"},{"key":"4788_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.956181","volume":"13","author":"G Chen","year":"2022","unstructured":"Chen G, Yang F, Fan S, Jin H, Liao K, Li X, Liu G-B, Liang J, Zhang J, Xu J-F (2022) Immunomodulatory roles of selenium nanoparticles: novel arts for potential immunotherapy strategy development. Front Immunol 13:956181. https:\/\/doi.org\/10.3389\/fimmu.2022.956181","journal-title":"Front Immunol"},{"issue":"1\u20132018","key":"4788_CR45","first-page":"31","volume":"5","author":"A Keyhani","year":"2018","unstructured":"Keyhani A, Mahmoudvand H, Shakibaie M, Kareshk AT, Nejati J, Mirbadie SR, Sadooghian S, Firoozeh N, Ziaali N (2018) Histopathological and toxicological study of selenium nanoparticles in BALB\/C Mice. Entomol Appl Sci Lett 5(1\u20132018):31\u201335","journal-title":"Entomol Appl Sci Lett"},{"issue":"3","key":"4788_CR46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jtemb.2012.11.002","volume":"27","author":"N Beheshti","year":"2013","unstructured":"Beheshti N, Soflaei S, Shakibaie M, Yazdi MH, Ghaffarifar F, Dalimi A, Shahverdi AR (2013) Efficacy of biogenic selenium nanoparticles against Leishmania major: in vitro and in vivo studies. J Trace Elem Med Biol 27(3):203\u2013207. https:\/\/doi.org\/10.1016\/j.jtemb.2012.11.002","journal-title":"J Trace Elem Med Biol"},{"issue":"16","key":"4788_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202409021","volume":"21","author":"X Ling","year":"2025","unstructured":"Ling X, Dong Z, He J, Chen D, He D, Guo R, He Q, Li M (2025) Advances in polymer-based self\u2010adjuvanted nanovaccines. Small 21(16):2409021. https:\/\/doi.org\/10.1002\/smll.202409021","journal-title":"Small"},{"issue":"5","key":"4788_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2024.152839","volume":"229","author":"H Liu","year":"2024","unstructured":"Liu H, Shen J, Liu W, Liu D, Cheng L, Huang B (2024) Selenium nanoparticles enhance the anti-tumor immune responses of anti-4-1BB antibody and alleviate the adverse effects on mice. Immunobiology 229(5):152839. https:\/\/doi.org\/10.1016\/j.imbio.2024.152839","journal-title":"Immunobiology"},{"issue":"12","key":"4788_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122772","volume":"14","author":"VV Khabatova","year":"2022","unstructured":"Khabatova VV, Serov DA, Tikhonova IV, Astashev ME, Nagaev EI, Sarimov RM, Matveyeva TA, Simakin AV, Gudkov SV (2022) Selenium nanoparticles can influence the immune response due to interactions with antibodies and modulation of the physiological state of granulocytes. Pharmaceutics 14(12):2772. https:\/\/doi.org\/10.3390\/pharmaceutics14122772","journal-title":"Pharmaceutics"},{"key":"4788_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101102","volume":"76","author":"Q Bu","year":"2024","unstructured":"Bu Q, Jiang D, Yu Y, Deng Y, Chen T, Xu L (2024) Surface chemistry engineered selenium nanoparticles as bactericidal and immuno-modulating dual-functional agents for combating methicillin-resistant Staphylococcus aureus infection. Drug Resist Updat 76:101102. https:\/\/doi.org\/10.1016\/j.drup.2024.101102","journal-title":"Drug Resist Updat"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04788-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-04788-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04788-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:40:42Z","timestamp":1776746442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-04788-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4788"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-04788-3","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Animal study protocols were found to follow ethical principles, national norms, and standards for conducting Medical Research in Iran. The Islamic Azad Tehran Medical Sciences University, Pharmaceutical Faculty, approved all experimental procedures (IR.IAU.PS.REC.1400.239).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}],"article-number":"211"}}